Quantcast

Latest balloon catheter Stories

2011-01-09 23:01:00

PLEASANTON Calif., SINGAPORE and TOKYO, Jan. 10, 2011 /PRNewswire/ -- TriReme Medical, Inc. (TriReme) today announced that it has signed an exclusive distribution and sales agreement for TriReme's complete line of advanced peripheral and coronary balloon dilatation catheters with Century Medical, Inc. (CMI), a leading independent device distributor for the important Japanese market. TriReme recently received clearance from the U.S. Food and Drug Administration (FDA) for the...

2010-12-23 12:36:00

MOUNTAIN VIEW, Calif., Dec. 23, 2010 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that Guy Mayeda, MD, interventional cardiologist at Good Samaritan Hospital in Los Angeles, California, performed the first commercial deployment of the company's IQCath(TM) Balloon Dilatation Catheter. This new device enables, for the first time, performance of three complex vascular procedures with one single catheter, potentially reducing procedure time and expense for both patients and...

2010-12-14 00:01:42

Today Insightra Medical, one of the fastest growing medical device companies announced the expansion of cardiology products by the addition of a line of Coronary Dilatation Balloons (CDB). Irvine, CA (PRWEB) December 12, 2010 Insightra Medical, Irvine, CA, is aggressively targeting three major sectors of the medical device market: Cardiovascular, General Surgery and Urogynecology. Key to Insightra's growth is the continual addition of new product ranges to offer a full compliment of...

2010-11-03 08:31:00

TORONTO, Nov. 3, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, novel drug-coated balloon technology is being adopted in niche applications throughout Europe. This market will continue to grow as physicians increasingly use the technology in cases where other devices may not be suitable. Although drug-coated balloons lack extensive clinical data comparing their efficacy against other technologies, such as...

2010-10-20 09:00:00

LAGUNA HILLS, Calif., Oct. 20 /PRNewswire/ -- Minnow Medical, Inc., a developer of a novel platform technology employing radiofrequency thermoplasty for the treatment of in-stent restenosis and other peripheral vascular conditions, announced today that it had closed two separate financing transactions valued at an aggregate of $4.7 million. The transactions consisted of the sale of $3.2 million in preferred stock and $1.5 million in convertible notes that convert into preferred stock....

2010-09-23 12:03:00

WASHINGTON, Sept. 23 /PRNewswire/ -- Lutonix, Inc., headquartered in Minneapolis, MN, today announced six-month data from three separate drug coated balloon studies presented at the TransCatheter Therapeutics (TCT) meeting this week demonstrated the ability of the Moxy(TM) Drug Coated Balloon Catheter to inhibit restenosis in both peripheral and coronary arteries. In all three clinical trials, the drug coated balloon therapy demonstrated a clear biologic effect as measured by six month...

a24a64d166149a2ea8947d15549f2e351
2010-08-10 19:36:13

A new optical imaging technique described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics, holds the potential to greatly improve angioplasty, a surgery commonly performed to treat patients with a partially or completely blocked coronary artery that restricts blood flow to the heart.Angioplasty involves threading a slender, balloon-tipped tube from an artery in the groin to the trouble spot in the artery of the heart. The balloon is...

2010-08-05 09:09:00

WALTHAM, Mass., Aug. 5 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Invatec has traditionally held a much stronger position in the European percutaneous transluminal angioplasty (PTA) balloon catheter market compared to the US. Nonetheless, sales of Invatec's PTA balloon catheters picked up in the US in Q1 2010, according to MRG's Peripheral Vascular Marketrack(TM) study, coinciding with Medtronic's...

2010-07-30 05:00:00

MOUNTAIN VIEW, Calif., July 30 /PRNewswire/ -- Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients. These new Hotspur devices are focused on solving some of the key...

2010-06-24 05:00:00

WEBSTER, Texas, June 24 /PRNewswire/ -- IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme(TM) PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market. The PAD market represents more...


Latest balloon catheter Reference Libraries

Interventional Radiology
2013-03-04 16:18:42

Interventional radiology (IR) is a special sub-operation under general radiology. It is used to find, diagnose and treat a disease in almost every body system. The process of interventional radiology is very noninvasive to help with the recovery and outcome of the procedure. It utilizes x-rays, CT, ultrasound, MRI, and other modes of imaging in order to direct tools in the body as well as a variety of catheters, narrow tubes, so that incisions can be minimalized. How it is Performed...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related